Evidence map›Paper›PMID 30014315›Full record

ArticleCNS drugs2018

Association Between Psychotropic Medication Polypharmacy and an Objective Measure of Balance Impairment Among Middle-Aged Adults: Results from the US National Health and Nutrition Examination Survey.

Natalie Bareis, Trisha A Sando, Briana Mezuk, Steven A Cohen

Open access · greenAbstract read
In one paragraph

Article in CNS drugs, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
4.5field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Gene alteration in zebrafish exposed to a mixture of substances of abuse.Environmental pollution (Barking, Essex : 1987) · 2021
    Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Natalie BareisDepartment of Psychiatry, Columbia University Medical Center and the New York State Psychiatric Institute, 1051 Riverside Drive, Room 6402A, New York, NY, USA. natalie.bareis@nyspi.columbia.edu.ORCID http://orcid.org/0000-0002-9067-2075
Trisha A SandoDivision of Epidemiology, Department of Internal Medicine and Population Health, Virginia Commonwealth University, Richmond, VA, USA.
Briana MezukDivision of Epidemiology, Department of Internal Medicine and Population Health, Virginia Commonwealth University, Richmond, VA, USA.
Steven A CohenDepartment of Kinesiology, University of Rhode Island, Kingston, RI, USA.
Virginia Commonwealth University · USColumbia University Irving Medical Center · USUniversity of Rhode Island · US

Funding

Research Training in Late-Life NeuroPsychiatric DisordersT32MH020004 · NIMH · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Patrick J Brown · 1998 to 2026
$6.1M
Depression, inflammation, and diabetes: Exploring shared etiopathologyK01MH093642 · NIMH · VIRGINIA COMMONWEALTH UNIVERSITY · PI MEZUK, BRIANA · 2012 to 2015
$689k
NIMH NIH HHS K01 MH093642NIMH NIH HHS T32 MH020004
6 · The paper itself

Abstract

objectivePsychotropic medications (e.g., antidepressants, anxiolytics, and neuroleptics) are increasingly prescribed with two or more taken concurrently (polypharmacy), and have been associated with an increased risk of falling. The aim of this study was to examine the association between psychotropic medication use and balance impairment using an objective balance measure.

methodsWe derived data from participants aged 40 years and older in the US National Health and Nutrition Examination Survey (1999/00-2003/04) who completed the Modified Clinical Trial of Sensory Interaction and Balance and indicated current medications (n = 3090). Balance impairment was defined as failing the Modified Clinical Trial of Sensory Interaction and Balance condition 4 (standing on foam surface, eyes closed). Medication use included specific psychotropic classes, a count of psychotropic medications, and a count of non-psychotropic medications taken concurrently. Nested multiple logistic regression assessed relationships between medication use and balance impairment, adjusting for covariates and complex sampling.

resultsOne third of participants had balance impairment. After accounting for medical comorbidities, there was no relationship between individual classes of psychotropic medications and balance impairment. After adjusting for all covariates, there was a dose-response relationship between the number of psychotropic medications taken and balance impairment, with every additional medication associated with a 35% higher odds (odds ratio = 1.35; 95% confidence interval 1.07-1.70). In comparison, there was no increase in the odds of balance impairment associated with each additional medication taken for participants only taking non-psychotropic medications.

conclusionsPsychotropic medication polypharmacy is associated with an increased odds of balance impairment. Clinicians should exercise caution when prescribing combinations of psychotropic medications, and refer to physical therapy for assessment and treatment if balance impairment is detected.

Indexed as

Nutrition SurveysAdultAge FactorsBody Mass IndexDemographyFemaleHumansLogistic ModelsMaleMiddle AgedPolypharmacyPsychotic DisordersPsychotropic DrugsSensation DisordersSex FactorsUnited StatesPsychotropic Drugs

Identifiers

PMID30014315
PMCPMC6146074
OpenAlexW2884555069

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.